OPFOLDA 65 MG Oral Capsule

RxCUI: 2667432
RxNorm name: OPFOLDA 65 MG Oral Capsule
Display name: OPFOLDA 65 MG Oral Capsule
Full name: OPFOLDA 65 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OPFOLDA	MIGLUSTAT	AMICUS THERAPEUTICS US, LLC	d7c38298-37db-5a80-e053-2995a90aee40	2024-11-27	Warnings, Adverse reactions	Exact identifier rxcui: 2667432

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
d7c38298-37db-5a80-e053-2995a90aee40	OPFOLDA 65 MG Oral Capsule [PSN] · miglustat 65 MG Oral Capsule [Opfolda] [SBD] · Opfolda 65 MG Oral Capsule [SY]	3	5	These highlights do not include all the information needed to use OPFOLDA ® safely and effectively. See full prescribing information for OPFOLDA. OPFOLDA (miglustat) capsules, for oral use Initial U.S. Approval: 2003	20241127